In recent years, MSC s have emerged as a promising therapeutic cell type in regenerative
medicine. They hold great promise for treating cardiovascular diseases, such as myocardial …

Mesenchymal stem cells (MSCs) have shown their therapeutic potency for treatment of
cardiovascular diseases owing to their low immunogenicity, ease of isolation and …

Mesenchymal stem cells (MSCs) have tremendous potential for regenerative medicine, and
have been researched for the treatment of cardiovascular diseases. MSCs are a promising …

The primary cause of death among chronic diseases worldwide is ischemic cardiovascular
diseases, such as stroke and myocardial infarction. Recent evidence indicates that adult …

Experimental and early clinical data suggest that, due to several unique properties,
mesenchymal stem cells (MSCs) may be more effective than other cell types for diseases …

Mesenchymal stem cells (MSCs) can generate multiple end-stage mesenchymal cell types
and constitute a promising population of cells for regenerative therapies. Additionally, there …

Atherosclerosis is a chronic inflammatory condition resulting in the formation of fibrofatty
plaques within the intimal layer of arterial walls. The identification of resident stem cells in …

Mesenchymal stem cells (MSCs) exhibit multipotent differentiation potential and can be
derived from embryonic, neonatal and adult differentiation stage III tissue sources. While …

Atherosclerosis is a complicated disorder and largely attributable to dyslipidaemia and
chronic inflammation. Despite therapeutic advances over past decades, atherosclerosis …

Ischemic diseases are conditions associated with the restriction or blockage of blood supply
to specific tissues. These conditions can cause moderate to severe complications in …